However, due to the distinctive molecular mechanisms underlying various neurodegenerative diseases, consequently, developing therapeutics targeting divergent upstream triggers or downstream effectors of cGAS-STING pathway is of critical importance[8]. This evidence concerns the gene CGAS and neurodegenerative disease.